Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency
NCT01327703
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
87
Enrollment
INDUSTRY
Sponsor class
Conditions
Exocrine Pancreatic Insufficiency
Cystic Fibrosis
Interventions
DRUG:
Panzytrat® 25,000
DRUG:
Kreon® 25,000
Sponsor
Forest Laboratories